While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical ...

January 19, 2012 — Multisite cryoablation of metastatic epithelial ovarian cancer is well tolerated, has a 5-year overall survival rate of 30%, and is cost effective, compared with other forms of ...

7-partial-nephrectomy-0516 Among patients with pT1b renal cell carcinoma, cryoablation is associated with a 2.5-fold higher 5-year cancer-specific mortality rate compared with partial nephrectomy, a ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical ...

Please provide your email address to receive an email when new articles are posted on . Cryoablation may be an effective primary treatment option for women with low-risk breast cancer, according to ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with early ...

Cryoablation is a fairly new treatment being used to treat small cancer tumors. Could we soon see it offered as an alternative to traditional breast cancer surgeries? There isn’t a day that goes by ...

NET of the lung: The experience of the Italian registry. Clinical features in surgically treated patients with small cell lung cancer: Risk of brain metastasis and possible role of prophylactic ...

Nephron-sparing surgery for small-to-medium sized renal tumors has undoubtedly become a standard of patient management in the 21 st century. The recent trends toward nephron sparing stem from an ...

External beam radiation therapy and cryoablation can both be used to treat localized prostate cancer. Quality of life outcomes are similar with the two forms of treatment, with the exception of sexual ...